loadpatents
Patent applications and USPTO patent grants for ALBERICI; Gilles.The latest application filed is for "novel il-17b antibodies".
Patent | Date |
---|---|
Novel Il-17b Antibodies App 20220281967 - BASTID; Jeremy ;   et al. | 2022-09-08 |
Antibodies Against Human Cd39 And Use Thereof App 20210261686 - Bensussan; Armand ;   et al. | 2021-08-26 |
Antagonists of IL-17 isoforms and their uses Grant 10,351,623 - Alberici , et al. July 16, 2 | 2019-07-16 |
Antagonists Of Il-17 Isoforms And Their Uses App 20180066051 - Alberici; Gilles ;   et al. | 2018-03-08 |
Antagonists of IL-17 isoforms and their uses Grant 9,834,601 - Alberici , et al. December 5, 2 | 2017-12-05 |
Il-17 Antagonist Antibodies App 20170233468 - ALBERICI; GILLES ;   et al. | 2017-08-17 |
IL-17 antagonist antibodies Grant 9,676,847 - Alberici , et al. June 13, 2 | 2017-06-13 |
Antagonists Of Il-17 Isoforms And Their Uses App 20150104456 - Alberici; Gilles ;   et al. | 2015-04-16 |
Il-17 Antagonist Antibodies App 20150104457 - Alberici; Gilles ;   et al. | 2015-04-16 |
Antibodies Against Human Cd39 And Use Thereof App 20130273062 - Bensussan; Armand ;   et al. | 2013-10-17 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.